USPTO serial 79146712
Reviewed by CopyMark Law Group
This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
40724 Hilden, DE
40724 Hilden, DE
Hilden, DE
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Daniel M. Gurfinkel
Daniel M. Gurfinkel Dennemeyer & Associates, LLC230 W. Monroe St.Suite 2100Chicago, IL 60606| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical, biochemical and biotechnological products for industrial and scientific purposes, namely, diagnostic preparations except for human or veterinary medical purposes, non-medical chemical reagents, enzymes and chemical solutions in the nature of buffer solutions for scientific and/or medical research use for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, amplifying, sequencing and/or for the analysis of bio polymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular chemical reagents, enzymes and chemical solutions in the nature of buffer solutions for nucleic acid amplification; kits comprising chemicals for laboratory or research use for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, amplifying, sequencing and/or for the analysis of bio polymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular nucleic acids of biological or biochemical sample material, in particular comprising chemicals for reagents, enzymes and buffer solutions for nucleic acid amplification | ACTIVE | — |
| 005 | Diagnostic preparations for medical purposes; diagnostic preparations for veterinary purposes; diagnostic preparations for humans for medical purposes; preparations for medical and veterinary purposes, namely, diagnostic preparations, for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, amplifying, sequencing and/or for the analysis of bio polymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular reagents, enzymes and buffer solutions for nucleic acid amplification; chemical, biochemical and biotechnological preparations for medical and veterinary purposes, namely, diagnostic reagents, enzymes and diagnostic reagents in the nature of buffer solutions for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, amplifying, sequencing and/or for the analysis of bio polymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular reagents, enzymes and buffer solutions for nucleic acid amplification; kits containing preparations for medical and veterinary diagnostic purposes, primarily consisting of diagnostic preparations for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, amplifying, sequencing and/or for the analysis of bio polymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular reagents, enzymes and buffer solutions for nucleic acid amplification | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 30, 2025 | NA75 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | — |
| Jun 30, 2025 | C75A | REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK. | — |
| Jun 30, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Mar 18, 2025 | ES75 | TEAS SECTION 71 & 15 RECEIVED | — |
| Apr 7, 2024 | REM4 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED | — |
| Jan 4, 2024 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Jun 16, 2021 | NA75 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | — |
| Jun 16, 2021 | C75A | REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK. | — |
| Jun 16, 2021 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Mar 18, 2021 | ES75 | TEAS SECTION 71 & 15 RECEIVED | — |
| Apr 7, 2020 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Oct 18, 2018 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Sep 4, 2015 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Aug 14, 2015 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Aug 14, 2015 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jul 7, 2015 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Apr 7, 2015 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 20, 2015 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 20, 2015 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 15, 2015 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Dec 31, 2014 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Dec 31, 2014 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Dec 31, 2014 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 13, 2014 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Dec 13, 2014 | ALIE | ASSIGNED TO LIE | — |
| Dec 2, 2014 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 25, 2014 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 24, 2014 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 24, 2014 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 23, 2014 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 23, 2014 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Aug 22, 2014 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jun 6, 2014 | RFNT | REFUSAL PROCESSED BY IB | — |
| May 22, 2014 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| May 22, 2014 | RFRR | REFUSAL PROCESSED BY MPU | — |
| May 21, 2014 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 20, 2014 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 20, 2014 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 16, 2014 | DOCK | ASSIGNED TO EXAMINER | — |
| May 16, 2014 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 15, 2014 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |